Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation (TRIST)
Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation: The TRIST Study
Sponsor: Canadian Blood Services
A PHASE3 clinical study on Hematologic Malignancies, this trial is completed. The trial is conducted by Canadian Blood Services and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Blood Services
- Canadian Institutes of Health Research (CIHR)
- Hamilton Health Sciences Corporation
- London Health Sciences Centre
- Ottawa Hospital Research Institute
- Saskatchewan Cancer Centre
- The Ottawa Hospital
For direct contact, visit the study record on ClinicalTrials.gov .